It was reported during a routine office visit, that this pacemaker device was suspected of behaving in a manner consistent with a premature battery depletion (pbd).A technical service (ts) consultant reviewed data with the physician, noting that the device battery longevity had eight years remaining in november 2020, and now the battery longevity is six months remaining.Ts discussed that the patient is in chronic atrial fibrillation since october 2021, (100% of every day).Thresholds have been increasing from 1.1v to 1.6v.Ts provided recommendations for programming to help extend battery longevity.Ts confirmed this device does not have a premature battery depletion.The physician will recheck the patient in 3 months.The device remains implanted.No adverse patient effects were reported.
|
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.The associated investigation determined that this device exhibited sensing of chronic high atrial rates which may impact battery longevity over time.Chronic high atrial sensing rates, such as for patients with chronic atrial fibrillation, can reduce longevity in devices that are programmed with atrial sensing on.Device power consumption increases proportional to the additional processing for sensed atrial events.As a result, the high rate of atrial sensing can result in the longevity being lower than expected, as observed with this device.
|